New study tests text reminders and counseling to stop fentanyl overdoses
NCT ID NCT07219082
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called BSAFE that uses counseling, text reminders, and help connecting to care to reduce overdose risk in people who use stimulants like cocaine or methamphetamine and may accidentally use fentanyl. 160 adults will be randomly assigned to the BSAFE program or a control group watching videos. Researchers will track overdoses and fentanyl use over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (counseling, text reminders, linkage to care)
What this could lead to
If successful, this could provide an effective, low-cost program to prevent accidental fentanyl overdoses in people who use stimulants.
What could go wrong
This is a small, early-stage behavioral trial. The intervention may not change behavior enough to reduce overdoses, and results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG OVERDOSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
San Francisco Department of Public Health
San Francisco, California, 94102, United States